Platelet response to aspirin and clopidogrel in patients with peripheral atherosclerosis

Esben Hjorth Madsen1, Norbert Rudolf Gehr, Nils Lauge Johannesen

  • 1Department of Internal Medicine, Viborg Hospital , Heibergs Allé 4, 8800 Viborg, Denmark. ehmadsen@gmail.com

Platelets
|May 20, 2011
PubMed

Insights

Assessing antiplatelet drug response in peripheral artery disease (PAD) patients reveals low aspirin response is rare, but high residual platelet reactivity is common and inconsistent. Clopidogrel response varies significantly by measurement method.

Area of Science:

  • Cardiology
  • Pharmacology
  • Vascular Medicine

Background:

  • Aspirin and clopidogrel are crucial for preventing ischemic events after treatment.
  • Individual responses to these antiplatelet drugs vary, with high residual platelet reactivity being a risk factor.
  • Peripheral artery disease (PAD) patients may show greater residual platelet reactivity than coronary heart disease patients.

Purpose of the Study:

  • To compare the comparability of three platelet reactivity tests for assessing low response to aspirin and clopidogrel in PAD patients.
  • To evaluate the consistency of platelet response measurements over time.

Main Methods:

  • Compared Platelet Function Analyzer-100 (PFA), light transmission aggregometry (LTA), and whole blood impedance aggregometry (IA) in 263 PAD patients.
  • Assessed platelet function twice, 3 months apart.
  • Investigated the effect of a 600 mg clopidogrel dose on platelet function in 43 patients.

Main Results:

  • Low response to aspirin (targeting cyclooxygenase-1 activity) was rare (≤ 8.1%) using LTA and IA.
  • The PFA identified 17% with low aspirin response at both visits, with 23% showing inconsistent responses.
  • Low response to clopidogrel varied from 0-23% depending on the method and criteria used.

Conclusions:

  • Low aspirin response, defined by lack of COX-1 inhibition, is uncommon.
  • High residual platelet reactivity, detected by PFA, is frequent in PAD patients but may not be consistent over time.
  • The assessment of clopidogrel response is highly dependent on the specific assay and definition employed.

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...